Diurnal Group PLC Director Dealings and Issue of Equity (7455E)
09 Julio 2021 - 2:30AM
UK Regulatory
TIDMDNL
RNS Number : 7455E
Diurnal Group PLC
09 July 2021
9 July 2021
Diurnal Group plc
("Diurnal" or the "Company")
Director Dealings and Issue of Equity
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical
company targeting patient needs in chronic endocrine (hormonal)
diseases, announces the issue and allotment of 973,682 ordinary
shares of GBP0.05 under the Diurnal Group plc Long Term Incentive
Plan (the "Plan"), including 679,768 new Shares to persons
discharging managerial responsibilities ("PDMR").
PDMR Total number of New Nature of issuance
Ordinary Shares issued
Martin Whitaker 376,230 Vesting of deferred bonus award
Richard Bungay 225,738 Vesting of deferred bonus award
Richard Ross 77,800 Vesting of deferred bonus award
The shares were issued under the Company's Employee Benefit
Trust scheme.
Martin Whitaker and Richard Bungay have informed the Company
that they intend to sell sufficient shares to pay all or part of
their personal tax liability arising from the vesting of their
deferred bonus awards once the New Ordinary Shares have been
admitted for trading on AIM and will retain the balance of shares.
These transactions will be subject to a further RNS announcement in
due course.
Following the issue of shares, the total beneficial interest of
Martin Whitaker and his connected parties is 980,053 Ordinary
Shares, representing 0.58% of the total voting rights, the total
beneficial interest of Richard Bungay is 339,990 Ordinary Shares,
representing 0.20% of the total voting rights, and the total
beneficial interest of Richard Ross and his connected parties is
2,262,155 Ordinary Shares, representing 1.34% of the total voting
rights.
Application has been made for admission of the 973,682 New
Ordinary Shares to trading on AIM, which is anticipated to occur at
8:00am on Monday 12 July 2021 ("Admission"). The New Ordinary
Shares will rank pari passu with the existing shares of common
stock of the Company. Following Admission, the Company's issued
ordinary share capital will consist of 168,903,690 ordinary shares.
The Company does not hold any shares in treasury. Therefore, the
total number of ordinary shares with voting rights in Diurnal
following Admission will be 168,903,690.
The above figure of 168,903,690 may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Details of the full notifications received by the Company are
set out below:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Martin Whitaker
------------------------------------- -----------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -----------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Acquisition of ordinary shares
------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------- -----------------
Price(s) Volume(s)
------------------- -----------------
Nil 376,230
-------------------------------------------------------------- -----------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 9 July 2021
------------------------------------- -----------------------------------------
f) Place of the transaction XLON
------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Bungay
------------------------------------- -----------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -----------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Acquisition of ordinary shares
------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------- -----------------
Price(s) Volume(s)
------------------- -----------------
Nil 225,738
-------------------------------------------------------------- -----------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 9 July 2021
------------------------------------- -----------------------------------------
f) Place of the transaction XLON
------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Ross
------------------------------------- -----------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Chief Scientific Officer
------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -----------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Acquisition of ordinary shares
------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------- -----------------
Price(s) Volume(s)
------------------- -----------------
Nil 77,800
-------------------------------------------------------------- -----------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 9 July 2021
------------------------------------- -----------------------------------------
f) Place of the transaction XLON
------------------------------------- -----------------------------------------
For further information, please visit www.diurnal.co.uk or
contact:
+44 (0)20 3727
Diurnal Group plc 1000
Martin Whitaker, Chief Executive Officer
Richard Bungay, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser +44 (0) 20 7886
and Sole Broker) 2500
Corporate Finance: Freddy Crossley, Emma Earl
Corporate Broking: Rupert Dearden
+44 (0)20 3727
FTI Consulting (Media and Investor Relations) 1000
Simon Conway
Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Diurnal Group plc is a European, UK-headquartered, specialty
pharmaceutical company dedicated to developing hormone therapeutics
to aid lifelong treatment for rare and chronic endocrine
conditions, including congenital adrenal hyperplasia, adrenal
insufficiency, hypogonadism and hypothyroidism. Its expertise and
innovative research activities focus on circadian-based
endocrinology to yield novel product candidates in the rare and
chronic endocrine disease arena.
For further information about Diurnal, please visit
www.diurnal.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFIFFDDIIAIIL
(END) Dow Jones Newswires
July 09, 2021 03:30 ET (07:30 GMT)
Diurnal (LSE:DNL)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Diurnal (LSE:DNL)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
